NotesFAQContact Us
Collection
Advanced
Search Tips
Laws, Policies, & Programs
No Child Left Behind Act 20011
What Works Clearinghouse Rating
Showing 1 to 15 of 74 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Michela Tinelli M; Aine Roddy; Martin Knapp; Celso Arango; Maria Andreina Mendez; James Cusack; Declan Murphy; Roberto Canitano; Bethany Oakley; Vinciane Quoidbach – Journal of Autism and Developmental Disorders, 2024
We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children's families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For…
Descriptors: Foreign Countries, Autism Spectrum Disorders, Epilepsy, Pharmacology
Peer reviewed Peer reviewed
Direct linkDirect link
Crutel, Véronique; Lambert, Estelle; Penelaud, Pierre-François; Albarrán Severo, Cristina; Fuentes, Joaquin; Rosier, Antoine; Hervás, Amaia; Marret, Stéphane; Oliveira, Guiomar; Parellada, Mara; Kyaga, Simon; Gouttefangeas, Sylvie; Bertrand, Marianne; Ravel, Denis; Falissard, Bruno – Journal of Autism and Developmental Disorders, 2021
There are currently no approved pharmacological treatments to improve social reciprocity and limit repetitive and rigid behaviors in autism spectrum disorder (ASD). We describe the design of two Phase III studies evaluating the efficacy/safety of bumetanide oral liquid formulation in ASD. These are international, multicenter, randomized,…
Descriptors: Autism, Pervasive Developmental Disorders, Children, Adolescents
Peer reviewed Peer reviewed
Direct linkDirect link
Tan, Mei; Bowers, Megan; Thuma, Phil; Grigorenko, Elena L. – New Directions for Child and Adolescent Development, 2020
Efavirenz (EFV) is a well-known, effective anti-retroviral drug long used in first-line treatment for children and adults with HIV and HIV/AIDS. Due to its narrow window of effective concentrations, between 1 and 4 µg/mL, and neurological side effects at supratherapeutic levels, several investigations into the pharmacokinetics of the drug and its…
Descriptors: Drug Therapy, Outcomes of Treatment, Acquired Immunodeficiency Syndrome (AIDS), Neurology
Peer reviewed Peer reviewed
Direct linkDirect link
Riccio, Cynthia A.; Pliego, Jessica; Rae, William A. – International Journal of School & Educational Psychology, 2016
An increasing number of children experience chronic health issues that affect their academic and behavioral functioning, as well as psychological well-being. At the same time, psychological stress can exacerbate the chronic illness. The first line of treatment most often is medical (e.g., pharmacology, surgery, radiation). Even when the medical…
Descriptors: Chronic Illness, Metacognition, Intervention, Well Being
Peer reviewed Peer reviewed
Direct linkDirect link
Scahill, Lawrence; Sukhodolsky, Denis G.; Anderberg, Emily; Dimitropoulos, Anastasia; Dziura, James; Aman, Michael G.; McCracken, James; Tierney, Elaine; Hallett, Victoria; Katz, Karol; Vitiello, Benedetto; McDougle, Christopher – Autism: The International Journal of Research and Practice, 2016
Repetitive behavior is a core feature of autism spectrum disorder. We used 8-week data from two federally funded, multi-site, randomized trials with risperidone conducted by the Research Units on Pediatric Psychopharmacology Autism Network to evaluate the sensitivity of the Children's Yale-Brown Obsessive Compulsive Scale modified for autism…
Descriptors: Autism, Pervasive Developmental Disorders, Scores, Networks
Peer reviewed Peer reviewed
Direct linkDirect link
Siegel, Matthew; Beaulieu, Amy A. – Journal of Autism and Developmental Disorders, 2012
This paper presents a systematic review, rating and synthesis of the empirical evidence for the use of psychotropic medications in children with autism spectrum disorders (ASD). Thirty-three randomized controlled trials (RCTs) published in peer-reviewed journals qualified for inclusion and were coded and analyzed using a systematic evaluative…
Descriptors: Evidence, Autism, Pharmacology, Drug Therapy
Shahidullah, Jeffrey D. – Communique, 2012
Psychotropic medications are increasingly used to treat children and adolescents with mental health conditions. Between the years 1994 and 2001, there was a 191.7% increase in number of office visits resulting in a psychotropic medication prescription among children and adolescents. Many drugs are prescribed to children "off-label", whereby they…
Descriptors: Drug Therapy, Mental Health, Children, Adolescents
Peer reviewed Peer reviewed
Direct linkDirect link
Scahill, Lawrence; McCracken, James T.; Bearss, Karen; Robinson, Fay; Hollander, Eric; King, Bryan; Bregman, Joel; Sikich, Lin; Dukes, Kimberly; Sullivan, Lisa; Anagnostou, Evdokia; Donnelly, Craig; Kim, Young-Shin; Ritz, Louise; Hirtz, Deborah; Wagner, Ann – Journal of Autism and Developmental Disorders, 2012
The Studies to Advance Autism Research and Treatment Network conducted a randomized trial with citalopram in children with Pervasive developmental disorders (PDDs). We present the rationale, design and sample characteristics of the citalopram trial. Subjects (128 boys, 21 girls) had a mean age of 9.3 (plus or minus 3.12) years; 132 (88.6%) were…
Descriptors: Pharmacology, Drug Therapy, Pervasive Developmental Disorders, Autism
Peer reviewed Peer reviewed
Direct linkDirect link
Davis, Andrew S.; Salpekar, Jay A. – Psychology in the Schools, 2009
Medications administered in clinical practice obtain their therapeutic effect only to the extent that the drug is present in the appropriate concentration at the desired site. To achieve this goal, the prescribing clinician must be aware of how a drug may interact with the physiology of the patient. Pharmacokinetics is the study of this process…
Descriptors: Pharmacology, Physiology, Children, Adults
Peer reviewed Peer reviewed
Direct linkDirect link
Stein, Zachary – Mind, Brain, and Education, 2010
The use of educationally oriented biotechnology has grown drastically in recent decades and is likely to continue to grow. Advances in both the neurosciences and genetics have opened up important areas of application and industry, from psychopharmacology to gene-chip technologies. This article reviews the current state of educationally oriented…
Descriptors: Pharmacology, Genetics, Etiology, Ethics
Peer reviewed Peer reviewed
Direct linkDirect link
van den Anker, Johannes N. – Developmental Disabilities Research Reviews, 2010
Understanding the pharmacokinetics and pharmacodynamics of drugs used in psychopharmacology across the pediatric age spectrum from infants to adolescents represents a major challenge for clinicians. In pediatrics, treatment protocols use either standard dose reductions for these drugs for children below a certain age or use less conventional…
Descriptors: Metabolism, Narcotics, Developmental Disabilities, Pharmacology
Peer reviewed Peer reviewed
Direct linkDirect link
Valkenburg, Abraham J.; van Dijk, Monique; de Klein, Annelies; van den Anker, Johannes N.; Tibboel, Dick – Developmental Disabilities Research Reviews, 2010
The primary focus of pain research in intellectually disabled individuals is still on pain assessment. Several observational pain assessment scales are available, each with its own characteristics, its own target group and its own validated use. Observational studies report differences in the treatment of intra- and postoperative pain of…
Descriptors: Pain, Down Syndrome, Mental Retardation, Outcomes of Treatment
Peer reviewed Peer reviewed
Direct linkDirect link
Joshi, Gagan; Petty, Carter; Wozniak, Janet; Henin, Aude; Fried, Ronna; Galdo, Maribel; Kotarski, Meghan; Walls, Sarah; Biederman, Joseph – Journal of Autism and Developmental Disorders, 2010
The objective of the study was to systematically examine patterns of psychiatric comorbidity in referred youth with autism spectrum disorders (ASD) including autistic disorder and pervasive developmental disorder not otherwise specified. Consecutively referred children and adolescents to a pediatric psychopharmacology program were assessed with…
Descriptors: Autism, Pharmacology, Pervasive Developmental Disorders, Comparative Analysis
Peer reviewed Peer reviewed
Direct linkDirect link
Huemer, J.; Erhart, F.; Steiner, H. – Child Psychiatry and Human Development, 2010
PTSD in children and adolescents differs from the adult disease. Therapeutic approaches involve both psychotherapy and psychopharmacotherapy. Objectives: The current paper aims at reviewing studies on psychopharmacological treatment of childhood and adolescent PTSD. Additionally, developmental frameworks for PTSD diagnosis and research along with…
Descriptors: Posttraumatic Stress Disorder, Pharmacology, Identification, Adolescents
Peer reviewed Peer reviewed
Direct linkDirect link
Reilly, Colin J. – Research in Developmental Disabilities: A Multidisciplinary Journal, 2011
ADHD and epilepsy common are both common childhood disorders and both can have significant negative consequences on a child's behavioural, learning, and social development. Both conditions can co-occur and population studies suggest that the prevalence of ADHD in childhood epilepsy is between 12 and 17%. The prevalence of epilepsy in ADHD is lower…
Descriptors: Epilepsy, Incidence, Mental Retardation, Quality of Life
Previous Page | Next Page »
Pages: 1  |  2  |  3  |  4  |  5